How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Police bodycam footage captured a 64-year-old Thai woman as she lay trapped in the coils of a python. Arom Arunrot was found lying on the floor of her house with the python, one of the largest snakes ...

This could bring more clarity and certainty for businesses on Trump's ultimate tariff structure, along with dread in foreign trade ministries that they may have to cough up more concessions to protect ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...